205 related articles for article (PubMed ID: 38674367)
1. Gene Dosage of
Gemmati D; D'Aversa E; Antonica B; Grisafi M; Salvatori F; Pizzicotti S; Pellegatti P; Ciccone M; Moratelli S; Serino ML; Tisato V
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674367
[TBL] [Abstract][Full Text] [Related]
2.
Gemmati D; Longo G; Franchini E; Araujo Silva J; Gallo I; Lunghi B; Moratelli S; Maestri I; Serino ML; Tisato V
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34207366
[TBL] [Abstract][Full Text] [Related]
3. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.
Dahlbäck B
Int J Lab Hematol; 2016 May; 38 Suppl 1():4-11. PubMed ID: 27161771
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
Gemmati D; Serino ML; Moratelli S; Tognazzo S; Ongaro A; Scapoli GL
Haemostasis; 2001; 31(2):99-105. PubMed ID: 11684865
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
Guasch JF; Lensen RP; Bertina RM
Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
[TBL] [Abstract][Full Text] [Related]
6. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
[TBL] [Abstract][Full Text] [Related]
7. Factor V Leiden: a disorder of factor V anticoagulant function.
Castoldi E; Rosing J
Curr Opin Hematol; 2004 May; 11(3):176-81. PubMed ID: 15257017
[TBL] [Abstract][Full Text] [Related]
8. [Phenotypic and genetic analysis of a pedigree affected with hereditary FV deficiency due to a novel deletional variant of F5 gene].
Ding H; Su K; Hu L; Zhang H; Zhu L; Yang L; Jin Y; Wang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Nov; 36(11):1100-1103. PubMed ID: 31703135
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299Arg substitutions in factor V.
Castaman G; Lunghi B; Missiaglia E; Bernardi F; Rodeghiero F
Br J Haematol; 1997 Nov; 99(2):257-61. PubMed ID: 9375735
[TBL] [Abstract][Full Text] [Related]
10. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.
Brugge JM; Simioni P; Bernardi F; Tormene D; Lunghi B; Tans G; Pagnan A; Rosing J; Castoldi E
J Thromb Haemost; 2005 Dec; 3(12):2695-702. PubMed ID: 16359508
[TBL] [Abstract][Full Text] [Related]
11. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Dahlbäck B
Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
[TBL] [Abstract][Full Text] [Related]
12. Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes.
Segers O; Simioni P; Tormene D; Bulato C; Gavasso S; Rosing J; Castoldi E
J Thromb Haemost; 2012 Jan; 10(1):73-80. PubMed ID: 22044617
[TBL] [Abstract][Full Text] [Related]
13. Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma.
Castoldi E; Duckers C; Radu C; Spiezia L; Rossetto V; Tagariello G; Rosing J; Simioni P
J Thromb Haemost; 2011 May; 9(5):959-68. PubMed ID: 21320286
[TBL] [Abstract][Full Text] [Related]
14. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
[TBL] [Abstract][Full Text] [Related]
15. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
[TBL] [Abstract][Full Text] [Related]
16. Low risk of venous thrombosis in two families with combined type I plasminogen deficiency and factor V R506Q mutation.
Castaman G; Ruggeri M; Tosetto A; Rodeghiero F
Am J Hematol; 1998 Apr; 57(4):344-7. PubMed ID: 9544982
[TBL] [Abstract][Full Text] [Related]
17. Two mutations in exon XII of the protein S alpha gene in four thrombophilic families resulting in premature stop codons and depressed levels of mutated mRNA.
Andersen BD; Lind B; Philips M; Hansen AB; Ingerslev J; Thorsen S
Thromb Haemost; 1996 Aug; 76(2):143-50. PubMed ID: 8865520
[TBL] [Abstract][Full Text] [Related]
18. Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation.
Castoldi E; Govers-Riemslag JW; Pinotti M; Bindini D; Tans G; Berrettini M; Mazzucconi MG; Bernardi F; Rosing J
Blood; 2003 Dec; 102(12):4014-20. PubMed ID: 12881304
[TBL] [Abstract][Full Text] [Related]
19. Determination of activated protein C resistance in anticoagulated and lupus positive patients.
Ivey LM; Thom JY; Ivey JG; Baker RI
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):439-45. PubMed ID: 10937805
[TBL] [Abstract][Full Text] [Related]
20. In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency.
Todaro AM; Radu CM; Ciccone M; Toffanin S; Serino ML; Campello E; Bulato C; Lunghi B; Gemmati D; Cuneo A; Hackeng TM; Simioni P; Bernardi F; Castoldi E
J Thromb Haemost; 2024 Feb; 22(2):410-422. PubMed ID: 37866515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
